Back to List View Graph View

Human gut flora

The human gut flora, also referred to as the gut microbiota or intestinal microbiome, comprises the vast and diverse community of microorganisms — predominantly bacteria, but also archaea, fungi, viruses, and protists — that colonize the gastrointestinal tract.

Where the papers sit

21 papers from the last 6 months study human gut flora directly · updated from PubMed 8 Oct 2026

Those 21 are all about one subject.

  • Gut Microbiome and Health

    Gut dysbiosis and microbial metabolites recur as links between diet, immunity, metabolism, neuroinflammation, infection and treatment response. Bile acids, linoleic acid and tryptophan-related pathways connect microbiota changes to kidney stones, neuropathic pain, Parkinsonian injury and long COVID. Dietary polyphenols, seed oils, paraprobiotics and other microbiome-directed interventions are being tested to restore metabolic and inflammatory balance. Evidence remains early and context-dependent, with mechanisms and durable clinical benefits still unresolved.

    21 papers

NEW DIRECTION

Gut microbiota is a transferable regulator of nanomedicine pharmacokinetics

Nanomedicine clearance and tumour delivery in germ-free and microbiota-manipulated mice were the subject of the study by PMID 42538384. Whereas the other papers use gut flora mainly as a contributor to disease phenotypes, immune states, metabolic pathways, or responses to biological treatments, this study found that gut-bacteria-derived bile acids program Kupffer-cell phagocytosis, thereby determining hepatic sequestration and the biodistribution of nanomedicines. Fecal transfer transmitted the low-clearance phenotype across multiple tumour models and nanomedicine formulations, making gut microbiota a transferable host pharmacokinetic determinant and a potential means of controlling drug delivery rather than merely a disease-related or treatment-associated variable.

Papers

The 21 papers from the last 6 months that study human gut flora directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.

By theme

Gut Microbiome and Health (21)
  1. Gut microbiota dysbiosis shapes brain T-cell immunity in accelerated aging. Gut microbes · 17 Sept 2026 PMID 42750596
  2. Chronic administration of a calafate (Berberis microphylla) polyphenol-rich extract modulates gut microbiota and metabolic homeostasis associated with thermogenic activation in high-fat diet-fed mice. Journal of physiology and biochemistry · 16 Sept 2026 PMID 42747643
  3. A prospective randomized controlled pilot study of gut microbiome modulation by Nigella sativa seed oil and thymoquinone metabolism in healthy volunteers: implications for gastrointestinal surgery. Scientific reports · 16 Sept 2026 PMID 42744850
  4. An upside of obesity: Diet-microbe synergy aids immunotherapy. Cell host & microbe · 9 Sept 2026 PMID 42715998
  5. Gut Microbiota-Isoallolithocholic Acid Crosstalk Promotes Calcium Oxalate Kidney Stone Formation via PARP1-Mediated Parthanatos. Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 29 Aug 2026 PMID 42666033
  6. Gut microbiome signatures during acute infection are associated with long COVID. Gut microbes · 19 Aug 2026 PMID 42615987
  7. Melatonin Ameliorates Neuropathic Pain in Mice by Regulating Pyroptosis Through Gut Microbiota-Mediated Linoleic Acid. Molecular neurobiology · 15 Aug 2026 PMID 42603252
  8. Use, understanding, and perceptions of gut microbiome research and practices in oncology. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 12 Aug 2026 PMID 42584704
  9. A transferable gut microbiota-bile acid pathway programs nanomedicine pharmacokinetics and therapeutic response. Nature materials · 31 Jul 2026 PMID 42538384
  10. Metabolic Mechanisms of Modified Lingguizhugan Decoction in Obesity and Lipid Metabolism Disorders: A Multi-Omics Approach. Obesity science & practice · 14 Jul 2026 PMID 42445565
  11. Lycium ruthenicum Murray anthocyanins alleviate neuroinflammation in MPTP-induced Parkinson's disease by modulating gut microbiota and tryptophan metabolism. International immunopharmacology · 20 Jun 2026 PMID 42322853
  12. Habitual Ultra-processed Food Intake Is Associated with Gut Dysbiosis and Pro-inflammatory Metabolite Profiles in Korean Patients with IBD. Digestive diseases and sciences · 19 Jun 2026 PMID 42319657
  13. Dietary purple sweet potato anthocyanin extracts attenuate intestinal barrier decline in naturally aged mice via the microbiota-autophagy-stem cell axis. Food & function · 19 Jun 2026 PMID 42316995
  14. Bridging the airway microbiome and targeted therapy in bronchiectasis: multi-omics insights, endotypes and emerging therapies. The European respiratory journal · 11 Jun 2026 PMID 42276744
  15. Antibiotic-mediated gut microbiota depletion partially attenuates methamphetamine-induced reward and linoleic acid metabolic disturbance. Neuropharmacology · 14 May 2026 PMID 42134644
  16. Paraprobiotics attenuate oxidative stress, dopaminergic neuron loss, and gut microbiome imbalance in an intranasal MPTP rat model of Parkinson's disease. Neuropharmacology · 9 May 2026 PMID 42105976
  17. Integrative multi-omics reveals that Pueraria thomsonii Radix alleviates dyslipidemia by remodeling gut microbiota and regulating arachidonic acid metabolism. Journal of ethnopharmacology · 7 May 2026 PMID 42097342
  18. Hydroxytyrosol Mitigates Anxiety-Like Behaviors After a Traumatic Experience in Aged Mice in Parallel With Increased Neurogenesis in the Ventral and Dorsal Dentate Gyrus, and Preservation of Gut Microbiota Composition. Journal of neurochemistry · 30 Apr 2026 PMID 42059580
  19. Interaction between Chinese olive (Canarium album L.) polyphenols and gut microbiota: Potential implications for inflammatory bowel disease. Journal of the science of food and agriculture · 28 Apr 2026 PMID 42046170
  20. Comorbid Alzheimer's Disease and Type 2 Diabetes Microbiota Shape Age-Associated Gut-Brain Axis Profiles. Aging cell · 22 Apr 2026 PMID 42015224
  21. Microbiota and immune-related adverse events in cancer immunotherapy. Nature reviews. Cancer · 16 Apr 2026 PMID 41992000

By study type

Clinical trials (1)
  1. A prospective randomized controlled pilot study of gut microbiome modulation by Nigella sativa seed oil and thymoquinone metabolism in healthy volunteers: implications for gastrointestinal surgery. Scientific reports · 16 Sept 2026 PMID 42744850
Observational studies and case reports (1)
  1. Gut microbiome signatures during acute infection are associated with long COVID. Gut microbes · 19 Aug 2026 PMID 42615987
Human data, design not indexed (2)
  1. Use, understanding, and perceptions of gut microbiome research and practices in oncology. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 12 Aug 2026 PMID 42584704
  2. Interaction between Chinese olive (Canarium album L.) polyphenols and gut microbiota: Potential implications for inflammatory bowel disease. Journal of the science of food and agriculture · 28 Apr 2026 PMID 42046170
Preclinical: animal, cell and lab studies (12)
  1. Gut microbiota dysbiosis shapes brain T-cell immunity in accelerated aging. Gut microbes · 17 Sept 2026 PMID 42750596
  2. Chronic administration of a calafate (Berberis microphylla) polyphenol-rich extract modulates gut microbiota and metabolic homeostasis associated with thermogenic activation in high-fat diet-fed mice. Journal of physiology and biochemistry · 16 Sept 2026 PMID 42747643
  3. An upside of obesity: Diet-microbe synergy aids immunotherapy. Cell host & microbe · 9 Sept 2026 PMID 42715998
  4. Melatonin Ameliorates Neuropathic Pain in Mice by Regulating Pyroptosis Through Gut Microbiota-Mediated Linoleic Acid. Molecular neurobiology · 15 Aug 2026 PMID 42603252
  5. A transferable gut microbiota-bile acid pathway programs nanomedicine pharmacokinetics and therapeutic response. Nature materials · 31 Jul 2026 PMID 42538384
  6. Lycium ruthenicum Murray anthocyanins alleviate neuroinflammation in MPTP-induced Parkinson's disease by modulating gut microbiota and tryptophan metabolism. International immunopharmacology · 20 Jun 2026 PMID 42322853
  7. Dietary purple sweet potato anthocyanin extracts attenuate intestinal barrier decline in naturally aged mice via the microbiota-autophagy-stem cell axis. Food & function · 19 Jun 2026 PMID 42316995
  8. Antibiotic-mediated gut microbiota depletion partially attenuates methamphetamine-induced reward and linoleic acid metabolic disturbance. Neuropharmacology · 14 May 2026 PMID 42134644
  9. Paraprobiotics attenuate oxidative stress, dopaminergic neuron loss, and gut microbiome imbalance in an intranasal MPTP rat model of Parkinson's disease. Neuropharmacology · 9 May 2026 PMID 42105976
  10. Integrative multi-omics reveals that Pueraria thomsonii Radix alleviates dyslipidemia by remodeling gut microbiota and regulating arachidonic acid metabolism. Journal of ethnopharmacology · 7 May 2026 PMID 42097342
  11. Hydroxytyrosol Mitigates Anxiety-Like Behaviors After a Traumatic Experience in Aged Mice in Parallel With Increased Neurogenesis in the Ventral and Dorsal Dentate Gyrus, and Preservation of Gut Microbiota Composition. Journal of neurochemistry · 30 Apr 2026 PMID 42059580
  12. Comorbid Alzheimer's Disease and Type 2 Diabetes Microbiota Shape Age-Associated Gut-Brain Axis Profiles. Aging cell · 22 Apr 2026 PMID 42015224
Unclassified: not yet indexed with MeSH (5)
  1. Gut Microbiota-Isoallolithocholic Acid Crosstalk Promotes Calcium Oxalate Kidney Stone Formation via PARP1-Mediated Parthanatos. Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 29 Aug 2026 PMID 42666033
  2. Metabolic Mechanisms of Modified Lingguizhugan Decoction in Obesity and Lipid Metabolism Disorders: A Multi-Omics Approach. Obesity science & practice · 14 Jul 2026 PMID 42445565
  3. Habitual Ultra-processed Food Intake Is Associated with Gut Dysbiosis and Pro-inflammatory Metabolite Profiles in Korean Patients with IBD. Digestive diseases and sciences · 19 Jun 2026 PMID 42319657
  4. Bridging the airway microbiome and targeted therapy in bronchiectasis: multi-omics insights, endotypes and emerging therapies. The European respiratory journal · 11 Jun 2026 PMID 42276744
  5. Microbiota and immune-related adverse events in cancer immunotherapy. Nature reviews. Cancer · 16 Apr 2026 PMID 41992000